{"artifact_id":"analysis-SDA-2026-04-16-gap-debate-20260410-113045-27c7b314","artifact_type":"analysis","title":"Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfunction in vivo? — Analysis","quality_score":0.4,"is_latest":1,"version_number":6,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{"derives_from":2,"related":24},"total_incoming":26,"outgoing_by_type":{"produces":1},"total_outgoing":1,"quality_trajectory":[{"score":0.4,"at":"2026-05-16T14:51:34.657673-07:00"},{"score":0.4,"at":"2026-05-16T08:03:22.955306-07:00"},{"score":0.4,"at":"2026-04-28T20:23:45.232071-07:00"},{"score":0.4,"at":"2026-04-28T20:23:45.232071-07:00"},{"score":0.4,"at":"2026-04-28T03:48:49.857966-07:00"}],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":27,"is_well_supported":false,"is_controversial":false,"is_foundational":true}